SignatureFD’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
SignatureFD's SMMT Position: Q3 2026 in Review
SignatureFD increased its Summit Therapeutics (SMMT) stake by 1,472% in Q3 2026, buying an estimated $16.7K and bringing the position to 1,195 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2417.
SignatureFD first reported a position in SMMT in Q4 2020 and has held it in 19 quarters since. 298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- SignatureFD held 1,195 shares of Summit Therapeutics worth $20.2K as of Q3 2026.
- SignatureFD bought 1,119 Summit Therapeutics shares in Q3 2026, an estimated $16.7K.
- Summit Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2417 holding.
- SignatureFD first reported a position in Summit Therapeutics in Q4 2020 and has held it in 19 quarters since.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.